Biotech NewsBiotech news continually updated from thousands of sources around the net.US warns of skin reactions with alcoholism drug- August 13, 2008 WASHINGTON : Federal regulators warned doctors Tuesday about severe skin reactions seen in patients taking an injectable treatment for alcoholism made by Alkermes Inc.http://www.topix.net/business/biotech/2008/08/us-warns-of-skin-reactions-with-alcoholism-d... CSL to acquire Talecris for $3.4b- August 13, 2008 Blood products and vaccine firm CSL Ltd will acquire Talecris Biotherapeutics Holdings Corp for $3.48 billion to boost its presence in the plasma therapeutics market.http://www.topix.net/business/biotech/2008/08/csl-to-acquire-talecris-for-3-4b?fromrss=1 Aeterna Zentaris Wid...- August 13, 2008 Cancer and endocrine drug developer AEterna Zentaris Inc. reported a widened second-quarter loss of US$20.6 million and named Jurgen Engel as its new president and CEO.http://www.topix.net/business/biotech/2008/08/aeterna-zentaris-wid?fromrss=1 Schering-Plough Expands Its Presence in China, Enters Next Stage of Development- August 12, 2008 Schering-Plough Corporation today announced that it has expanded its presence in China and established Shanghai Schering-Plough Pharmaceutical Co.http://www.topix.net/business/biotech/2008/08/schering-plough-expands-its-presence-in-chin... Enzon May Sell Specialty Pharma Unit- August 12, 2008 Enzon Pharmaceuticals is exploring strategic options for its specialty pharmaceuticals business.http://www.topix.net/business/biotech/2008/08/enzon-may-sell-specialty-pharma-unit?fromrss... Designer RNA Fights High Cholesterol- August 12, 2008 Small, specially designed bits of ribonucleic acid can interfere with cholesterol metabolism, reducing harmful cholesterol by two-thirds in pre-clinical tests, according to a new study by researchers at UT ...http://www.topix.net/business/biotech/2008/08/designer-rna-fights-high-cholesterol?fromrss... Alnylam inks deal with Max Planck- August 12, 2008 Alnylam Pharmaceuticals Inc. has signed a collaboration deal with a German research institute to find ways to make sure new RNAi treatments reach their targets.http://www.topix.net/business/biotech/2008/08/alnylam-inks-deal-with-max-planck?fromrss=1 FDA approves Gilead AIDS drug for hepatitis B- August 12, 2008 Gilead Sciences Inc. prepared to expand its reach further beyond AIDS drugs Monday after federal regulators approved the biotech drug maker's signature anti-HIV therapy as a hepatitis B treatment.http://www.topix.net/business/biotech/2008/08/fda-approves-gilead-aids-drug-for-hepatitis-... Enzon Pharmaceuticals Announces Intention to Explore Strategic...- August 12, 2008 Aug. 11, 2008 - Enzon Pharmaceuticals, Inc. announced today that it is exploring strategic alternatives for its specialty pharmaceuticals business.http://www.topix.net/business/biotech/2008/08/enzon-pharmaceuticals-announces-intention-to... EXACT Sciences Announces Next Generation Stool-Based DNA Technology...- August 11, 2008 EXACT Sciences Corporation announced the published results of a study in which stool and blood plasma were assessed, in a head-to-head comparison, for the detection of colorectal cancer .http://www.topix.net/business/biotech/2008/08/exact-sciences-announces-next-generation-sto... |